Transcriptional coactivator MED15 is required for beta cell maturation

AZ Kadhim, B Vanderkruk, S Mar, M Dan… - Nature …, 2024 - nature.com
Mediator, a co-regulator complex required for RNA Polymerase II activity, interacts with
tissue-specific transcription factors to regulate development and maintain homeostasis. We …

c-Jun N-terminal kinase signaling in aging

Y Li, L You, E Nepovimova, V Adam, Z Heger… - Frontiers in Aging …, 2024 - frontiersin.org
Aging encompasses a wide array of detrimental effects that compromise physiological
functions, elevate the risk of chronic diseases, and impair cognitive abilities. However, the …

[HTML][HTML] Proteomic predictors of individualized nutrient-specific insulin secretion in health and disease

J Kolic, WQG Sun, HH Cen, JD Ewald, JC Rogalski… - Cell Metabolism, 2024 - cell.com
Population-level variation and mechanisms behind insulin secretion in response to
carbohydrate, protein, and fat remain uncharacterized. We defined prototypical insulin …

Human A2-CAR T cells reject HLA-A2+ human islets transplanted into mice without inducing graft-versus-host disease

CE Ellis, M Mojibian, S Ida, VCW Fung, S Skovsø… - …, 2023 - journals.lww.com
Background. Type 1 diabetes is an autoimmune disease characterized by T-cell–mediated
destruction of pancreatic beta-cells. Islet transplantation is an effective therapy, but its …

[HTML][HTML] Tracking Insulin-and Glucagon-Expressing Cells In Vitro and In Vivo Using a Double-Reporter Human Embryonic Stem Cell Line

S Mar, E Filatov, S Sasaki, M Mojibian, D Zhang… - Diabetes, 2025 - diabetesjournals.org
Human embryonic stem cell (hESC)-derived pancreatic α-and β-cells can be used to
develop cell replacement therapies to treat diabetes. However, recent published …

Tracking insulin- and glucagon-expressing bihormonal cells during differentiation using an INSULIN and GLUCAGON double reporter human embryonic stem cell …

S Mar, E Filatov, C Nian, S Sasaki, D Zhang, FC Lynn - bioRxiv, 2023 - biorxiv.org
Human embryonic stem cell (hESC)-derived pancreatic alpha and beta cells can be used to
develop cell replacement therapies to treat diabetes. However, recent published …

Single cell glucose-stimulated insulin secretion assay using nanowell-in-microwell plates

D Jang, K Matthews, P Deng, SG Berryman, C Nian… - Lab on a Chip, 2024 - pubs.rsc.org
Pancreatic β cells secrete insulin in response to elevated levels of glucose. Stem cell
derived β (SCβ) cells aim to replicate this glucose-stimulated insulin secretion (GSIS) …

An INSULIN and IAPP dual reporter enables tracking of functional maturation of stem cell-derived insulin producing cells

CL Bayly, XQ Dai, C Nian, PC Orban, CB Verchere… - Molecular …, 2024 - Elsevier
Objective Human embryonic stem cell (hESC; SC)-derived pancreatic β cells can be used to
study diabetes pathologies and develop cell replacement therapies. Although current …

Truncated CD19 as a selection marker for the isolation of stem cell derived β-cells

LT Huang, D Zhang, C Nian, L Francis C - bioRxiv, 2023 - biorxiv.org
Stem cell-derived β-cells (SCβ-cell) are a renewable and scalable alternative to cadaveric
islets as a cell replacement therapy for type 1 diabetes (T1D). However, heterogeneity within …

Characterizing the effects of Dechlorane Plus on β-cells: a comparative study across models and species

KA van Allen, N Gang, MP Hoyeck, I Perera, D Zhang… - Islets, 2024 - Taylor & Francis
Epidemiological studies consistently link environmental toxicant exposure with increased
Type 2 diabetes risk. Our study investigated the diabetogenic effects of a widely used flame …